Plasma Rich in Growth Factors as an Adjuvant Agent in Non-Penetrating Deep Sclerectomy.
Pedro P Rodríguez-CalvoIgnacio Rodríguez-UnaAndrés Fernández-Vega-CuetoRonald M Sanchez-AvilaEduardo AnituaJesús Merayo-LlovesPublished in: Journal of clinical medicine (2023)
Topical is-ePRGF seems to reduce IOP and the rate of complications in the medium term after NPDS, so it can be considered as a possible safe adjuvant to achieve surgical success.